2006 Annual Meeting | Identification and Management of Ethical Issues in Neurological Practice

Date Tuesday 04/04/06

Time 02:15 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Michael A. Williams, MD, FAAN

Topic(s) Practice Management

Learning Objectives Upon Completion:
Participants should be able to describe the process and ethical dimensions of genetic testing and counseling and the different types of genetic testing in children and adolescents, including pre-symptomatic testing for treatable versus non treatable conditions and prenatal testing; discuss important principles and responsibilities in phase 4 clinical trials, including subject privacy and confidentiality, the distinction between research subjects and patients, the potential for bias in funded studies, and financial pressures to induct and maintain subjects in longitudinal trials; identify different statutorily created criteria for selecting decision makers and the standards they must use when making end-of-life decisions, the influence of legislation on long-standing presumptions regarding withdrawal or withholding of artificial nutrition and hydration, and important ethical and legal distinctions that influence end-of-life decisions and withdrawal of therapies for newborns and children; and distinguish neurological and philosophical concepts of consciousness and describe the relationship between consciousness and decision making capacity and its ethical relevance to surrogate decision making for neurologically impaired patients.

CME Available No CME available

Core Competencies Professionalism, Medical Knowledge, Systems-based Practice

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
02:15 PM - 02:20 PM		Introduction
02:20 PM - 02:55 PM		State Legislation Governing End-of-Life Decision Making in the United States Daniel G. Larriviere, MD, JD, FAAN
02:55 PM - 03:30 PM		Ethical and Legal Issues in End-of-Life Decisions for Newborns and Children Patricia A. Evans, MD, PhD, FAAP, FAAN
03:30 PM - 03:40 PM		Questions and Answers
03:40 PM - 03:55 PM		Break
03:55 PM - 04:30 PM		Ethical Dimensions of Consciousness in Neurology James Gordon, MD, FRCPC, FAAN
04:30 PM - 05:05 PM		Ethical Dimensions of Diagnostic, Presymptomatic, and Carrier Genetic Testing Tyler E. Reimschisel, MD, MHPE
05:05 PM - 05:40 PM		Ethical Issues Related to Participation in Phase 4 Clinical Trials for Neurologists in Community Practice Matthew Rizzo, MD, FAAN
05:40 PM - 06:00 PM		Questions and Answers

Faculty Disclosures
James Gordon, MD, FRCPC, FAAN	No disclosure on file
Matthew Rizzo, MD, FAAN	The institution of Dr. Rizzo has received research support from NIH.
Michael A. Williams, MD, FAAN	Dr. Williams has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for the Hydrocephalus Association, a not-for-profit patient advocacay organization. The institution of Dr. Williams has received research support from NASA. The institution of Dr. Williams has received research support from Translational Research Insitute for Space Health (TRISH). The institution of Dr. Williams has received research support from NINDS.
Patricia A. Evans, MD, PhD, FAAP, FAAN	Dr. Evans has nothing to disclose.
Daniel G. Larriviere, MD, JD, FAAN	Dr. Larriviere has nothing to disclose.
Tyler E. Reimschisel, MD, MHPE	No disclosure on file

��ɫ��

��ɫ��